Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2097401000168115 | hydrochlorothiazide 12.5 mg + irbesartan 300 mg tablet, 5 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2097411000168117 | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 5 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 5 | Is a | irbesartan 300 mg tablet, 5 | true | Inferred relationship | Some | ||
| irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 5 | has MPUU | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irbesartan HCT 300/12.5 (Sanofi) tablet, 5 | Is a | True | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 5 | Inferred relationship | Some | |
| Irbesartan HCTZ 300 mg/12.5 mg (Apotex) tablet, 5 | Is a | True | irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet, 5 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR